ConductScience.org, home

Paper20041335

Expression of metalloproteases and their inhibitors in primary tumors and in local recurrences after mastectomy for breast cancer.

del Casar JM and 8 others. J Cancer Res Clin Oncol, 2010. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Expression of metalloproteases and their inhibitors in primary tumors and in local recurrences after mastectomy for breast cancer. Papers, record 20041335. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20041335

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Expression of metalloproteases and their inhibitors in primary tumors and in local recurrences after mastectomy for breast cancer.
PubMed
Journal
J Cancer Res Clin Oncol
PubMed
Year
2010
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.25
iCite
Revised in PubMed
2025-07-19
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1del Casar JMJosé M
2Carreño GGuillermo
3González LOLuis O
4Junquera SSara
5González-Reyes SSalomé
6González JMJosé M
7Bongera MMiguel
8Merino AMAntonio M
9Vizoso FJFrancisco J

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
MastectomyMajor topic
Matrix MetalloproteinasesMajor topic
Neoplasm Recurrence, LocalMajor topic
Tissue Inhibitor of MetalloproteinasesMajor topic
Female
Humans
Immunohistochemistry
Middle Aged
Neoplasm Staging

Source PubMed

Download CSV of topics

References80

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111245340Matrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy.Breast Cancer Res Treat2001https://conductscience.org/library/papers/11245340PubMed
26830336The implications of local recurrence of breast cancer as the first site of therapeutic failure.Ann Surg1983https://conductscience.org/library/papers/6830336PubMed
39862716Matrix metalloproteinases generate angiostatin: effects on neovascularization.J Immunol1998https://conductscience.org/library/papers/9862716PubMed
416850244Local recurrence after mastectomy for breast cancer: analysis of clinicopathological, biological and prognostic characteristics.Breast Cancer Res Treat2007https://conductscience.org/library/papers/16850244PubMed
511112695Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1.J Cell Sci2001https://conductscience.org/library/papers/11112695PubMed
617589901Liver expression of steroid hormones and Apolipoprotein D receptors in hepatocellular carcinoma.World J Gastroenterol2007https://conductscience.org/library/papers/17589901PubMed
73998783Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer.J Clin Oncol1985https://conductscience.org/library/papers/3998783PubMed
84052951The effect of adjuvant radiotherapy on the time of occurrence and prognosis of local recurrence in primary operable breast cancer.Cancer1985https://conductscience.org/library/papers/4052951PubMed
910211085
Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group.
Eur J Cancer1999https://conductscience.org/library/papers/10211085PubMed
1012115876Enhanced mRNA expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in breast carcinomas is correlated with adverse prognosis.J Pathol2002https://conductscience.org/library/papers/12115876PubMed
119118223Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma.Cell1997https://conductscience.org/library/papers/9118223PubMed
12698698Natural history and prognosis of recurrent breast cancer.Br Med J1978https://conductscience.org/library/papers/698698PubMed
134508256Enhancement of experimental metastasis by x-ray: a possible mechanism.J Med1972https://conductscience.org/library/papers/4508256PubMed
1412354933Expression of proteinases and inhibitors in human breast cancer progression and survival.Mol Pathol2002https://conductscience.org/library/papers/12354933PubMed
156994873The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology--an overview of findings.Cancer1980https://conductscience.org/library/papers/6994873PubMed
1615609121Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype.Breast Cancer Res Treat2004https://conductscience.org/library/papers/15609121PubMed
171714241Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival.Am J Pathol1991https://conductscience.org/library/papers/1714241PubMed
184079434Local recurrence in the pectoralis muscles following modified radical mastectomy for carcinoma.J Surg Oncol1985https://conductscience.org/library/papers/4079434PubMed
1911357145The microenvironment of the tumour-host interface.Nature2001https://conductscience.org/library/papers/11357145PubMed
2011687497How matrix metalloproteinases regulate cell behavior.Annu Rev Cell Dev Biol2001https://conductscience.org/library/papers/11687497PubMed

See all 80 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
27434331Ionizing radiation-mediated premature senescence and paracrine interactions with cancer cells enhance the expression of syndecan 1 in human breast stromal fibroblasts: the role of TGF-β.Aging (Albany NY)2016https://conductscience.org/library/papers/27434331PubMed
25510449Expression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancer.BMC Cancer2014https://conductscience.org/library/papers/25510449PubMed
24338768Collagen as a double-edged sword in tumor progression.Tumour Biol2014https://conductscience.org/library/papers/24338768PubMed
23681802Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets.Tumour Biol2013https://conductscience.org/library/papers/23681802PubMed
22613484A new paradigm for mechanobiological mechanisms in tumor metastasis.Semin Cancer Biol2012https://conductscience.org/library/papers/22613484PubMed

Download CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20041335

GET https://conductscience.org/api/papers/v1/20041335/references?page=2